Literature DB >> 24900556

Treatment of Obesity and Related Disorders with Acetyl-CoA Carboxylase Inhibitors.

Ahmed F Abdel-Magid1.   

Abstract

Year:  2012        PMID： 24900556      PMCID： PMC4030798          DOI： 10.1021/ml3004044

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Lipogenic enzymes as therapeutic targets for obesity and diabetes.

Authors:  James M Lenhard
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 2.  Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.

Authors:  Clifford D L Folmes; Gary D Lopaschuk
Journal:  Cardiovasc Res       Date:  2006-10-20       Impact factor: 10.787

Review 3.  Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome.

Authors:  M Schreurs; F Kuipers; F R van der Leij
Journal:  Obes Rev       Date:  2009-08-20       Impact factor: 9.213

Review 4.  Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007-2008.

Authors:  Jeffrey W Corbett
Journal:  Expert Opin Ther Pat       Date:  2009-07       Impact factor: 6.674
  4 in total
  3 in total

1.  Leucine alters hepatic glucose/lipid homeostasis via the myostatin-AMP-activated protein kinase pathway - potential implications for nonalcoholic fatty liver disease.

Authors:  Aida Zarfeshani; Sherry Ngo; Allan M Sheppard
Journal:  Clin Epigenetics       Date:  2014-11-18       Impact factor: 6.551

2.  AZD1208, a pan-Pim kinase inhibitor, inhibits adipogenesis and induces lipolysis in 3T3-L1 adipocytes.

Authors:  Yu-Kyoung Park; Brice Wilfried Obiang-Obounou; Kyung-Bok Lee; Jong-Soon Choi; Byeong-Churl Jang
Journal:  J Cell Mol Med       Date:  2018-02-14       Impact factor: 5.310

Review 3.  The Beneficial Effects of Principal Polyphenols from Green Tea, Coffee, Wine, and Curry on Obesity.

Authors:  Tomokazu Ohishi; Ryuuta Fukutomi; Yutaka Shoji; Shingo Goto; Mamoru Isemura
Journal:  Molecules       Date:  2021-01-16       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.